NVC International Holdings Limited

FY2021 figures are the US$-restated five-year summary in the 2023 Annual Report [S4]. The detailed FY2021 line items (opex, D&A, cash flow) were reported only in RMB and are not reproduced in US$, so those cells are blank. FY2022–FY2025 line items come from [S3; S2; S1].

Income statement

How the derived lines are built:

Derived operating profit: gross profit + other income − S&D − admin − R&D (other expenses) ± expected-credit-loss (ECL) impairment movements. It excludes other gains and losses, associate impairment movements, associate results and finance costs.

Derived EBITDA: derived operating profit + total depreciation and amortisation (per the notes).

FY2021 tax: is derived as PBT minus profit for the year.

FY2021 EPS: is derived using 422.7m consolidation-adjusted shares.

Diluted EPS: equals basic because no potential ordinary shares were in issue [S1; S3].

Margins and growth (%)

Revenue CAGR.

• FY2021–FY2025 (4 years): −11.8% p.a.

• FY2022–FY2025 (3 years): −7.3% p.a.

• FY2019–FY2025, against a FY2019 base of US$322.4m [S4]: −6.0% p.a.

FY2021 growth of +8.1% is in US$ terms. In RMB, FY2021 revenue grew only about 1.1% (RMB2,374.9m vs RMB2,349.6m) [S20]. The gap reflects CNY appreciation.

Half-year decomposition (derived).

The FY2025 recovery was concentrated in H1 2025, when FX and fair-value gains (US$8.4m in other gains) carried the result. H2 2025 was loss-making at the attributable level, and the trailing twelve months to June 2026 show a small attributable loss [S1; S5].

Commentary: trends, inflections, drivers.

Revenue: Revenue roughly halved from its FY2021 peak, falling 39.5%. The drivers were: (i) post-COVID US destocking and the slump in US housing turnover (US revenue fell from US$169.7m in FY2022 to US$132.4m in FY2023); (ii) yen weakness and contraction in Japanese demand (Japan LED demand in 2024 was only 90% of 2023, per the Japan Lighting Manufacturers Association as cited in [S2]); (iii) continuous erosion of the PRC ODM business; and (iv) loss of UK volume to contractor insolvencies [S1; S2; S3].

Gross margin: Margin rose for three straight years (22.8% to 34.3%) after the FY2022 commodity and freight trough. This is the group's clearest operational achievement, but H1 2026 (32.9%) shows it is vulnerable to tariffs, metals and semiconductor or PCB inflation [S5].

Operating profit: Operating profit (derived) turned positive only in FY2024 (US$9.9m) and reached US$11.5m in FY2025. Opex fell from US$79.9m (FY2022) to US$70.7m (FY2025), but admin rose in FY2025 on redundancy costs [S1].

Bottom line: Net profit is dominated by the NVC China associate. Its contributions were:

• FY2022: a US$7.4m impairment

• FY2023: a US$24.2m reversal plus a US$17.2m share of profit, which together made up most of FY2023's US$40.4m PBT

• FY2024: a US$26.6m impairment

• FY2025: a US$0.8m share of loss

• H1 2026: a US$4.2m share of loss [S1; S2; S3; S5] FX and fair-value gains on the US$52m investment portfolio add further volatility. Core earning power is therefore roughly US$10–12m of pre-tax operating profit in a good year, before associates.

Balance sheet

Sources: FY2021 values are the restated 1 Jan 2022 balances in [S3]; FY2022–FY2023 [S3]; FY2024 [S2]; FY2025 [S1]. Net debt is derived; negative values denote net cash.

H1 2026 update (30 Jun 2026) [S5]:

• Cash US$122.98m; FVTPL US$52.97m

• Borrowings US$16.49m, of which RMB30m (US$4.4m) is due in October 2026 and RMB60m in October/December 2027

• Inventories US$50.36m

• Interests in associates US$121.61m

• Total equity US$491.76m; net current assets US$193.62m; current ratio 3.03

Commentary. The balance sheet carries no debt problem: net cash has exceeded US$90m every year. Working capital has been released dramatically, with inventories down 55% and trade payables down 58% from FY2021. Three features merit scrutiny:

1. Non-current deposits of US$42.6m (FY2025) have persisted since at least FY2022 (US$42.6m). Their nature is not explained in the announcements reviewed.

2. The FVTPL portfolio of about US$52m is managed by Parametric/Morgan Stanley under a discretionary mandate approved as a "major transaction" in late 2024 [S2]. It is a treasury asset, not an operating one.

3. The associate (BLIHP) carrying value of US$116.2m equals 24.4% of group net assets, and its recoverable amount (US$115.4m) already sat below carrying value at FY2025, though not by enough to trigger a further charge [S1].

Cash flow

Sources and notes:

• [S4; S3; S2; S1]

• FY2023 capex is US$6.98m per MD&A and US$6.92m per the segment note; the discrepancy reflects different definitions.

• FY2024 capex of US$20.95m includes the US$15.25m Georgia property.

• FY2024 and FY2025 full-year cash-flow statements are in the annual reports and were not reproduced in the results announcements reviewed, so those cells are blank.

• An aggregator shows FY2022 operating cash flow as RMB−58.6m [S19], but the 2023 Annual Report's comparative column could not be reliably reconciled, so FY2022 OCF is left blank.

• Interim figures: H1 2026 OCF US$7.27m (H1 2025: US$4.54m); H1 2026 capex US$2.55m (H1 2025: US$3.68m) [S5].

Ratios

All ratios are derived from [S1–S4] balances using period averages. FY2021 ROE and ROA use FY2020 balances from [S4]. ROIC uses invested capital = total equity + borrowings + leases − cash. Negative net debt/EBITDA denotes net cash.

Commentary. Returns are structurally poor. Even the best year (FY2023, 7.6% ROE) was associate-driven, and core ROIC is about 2%, far below any plausible cost of equity. The low asset turnover (0.39x) reflects that roughly 40% of total assets are cash, portfolio and associate holdings rather than operating assets. The cash conversion cycle improved by about 30 days since FY2023 on inventory discipline, but inventory rebuilt to US$50.4m by June 2026 (DIO rising again) as management pre-bought scarce components [S5].

Management guidance (qualitative only) [S1; S5]:

• International lighting remains the core business.

US: a "reset in consumer priorities" rather than a recession; the ETI commercial line is to be rationalised, the lighting department reintegrated, strategic suppliers changed, and AURA streamlined.

Japan: modest recovery but a slightly declining market; own-brand, e-commerce and ODM customer acquisition.

UK/Nordics: improvement expected in H2 2026.

SE Asia: Hanoi expansion; Belt-and-Road and Australia/NZ supermarket projects.

Costs: procurement measures against semiconductor, PCB and metals inflation.

• No numerical targets.

Consensus growth expectations. Not available (no coverage).

Bull case

1. Deep asset discount. At about US$42m market cap, the stock trades at roughly 24% of net financial assets (cash + FVTPL − borrowings ≈US$159.5m at Jun 2026, derived), with the NVC China stake (US$116m book) and the operating business implicitly valued below zero. Any monetisation event, such as a KKR exit or a sale of the 30%, could re-rate it.

2. Volume recovery is under way. H1 2026 revenue grew 11.5% with the US +14.6% and Japan +13.1% [S5]. Once tariff and input costs normalise, FY2025-type gross margins (34%) on a higher base imply derived operating profit above US$12m.

3. Optionality on capital return. With US$365m of distributable reserves (company level, FY2023) [S4] and no debt need, even a modest dividend would yield heavily on the current market cap.

Bear case

1. A governance discount that may be permanent. The family vehicle holds 29.85%, the chairman's son sits on the board, the CEO seat has been vacant for 17 months, there have been no dividends for six years, and US$50m of cash was placed in a discretionary portfolio rather than returned [S7; S5; S2]. Minority shareholders have no mechanism to force value realisation.

2. The associate is a value sink. BLIHP's recoverable amount was already below carrying value at FY2025 and it lost US$4.2m (NVC share) in H1 2026 amid the China property slump [S1; S5]. A further impairment in FY2026 is plausible.

3. Core earnings are thin and concentrated. About US$11m of derived operating profit depends on three customers (70% of revenue) and on US tariff policy. H1 2026 showed a 5pp gross-margin hit in one half-year [S5].

Key catalysts and monitorables (next 12 months).

• FY2026 results (≈late Mar 2027), especially any BLIHP impairment at FY2026 and H2 2026 gross-margin recovery.

• CEO appointment.

• KKR's intentions for NVC China.

• US tariff developments affecting Vietnam-sourced fixtures.

• Customer A/B/C volumes.

• Inventory build (US$50.4m at Jun 2026) and write-downs.

• Dividend or buyback policy at the FY2026 results.

• Outcome of the patent litigation.

• Treasury-portfolio performance.

• Repayment of the RMB30m tranche (Oct 2026).

Analyst verdict. NVC International is two companies wrapped in one governance structure. The first is a competent but structurally challenged lighting ODM. Over three years it has pushed gross margin from 23% to 34% by moving production to Vietnam and in-sourcing components, but revenue has fallen 40% since FY2021. It now depends on three US and Japanese retail customers for about 70% of sales and earns a derived operating margin of about 5%. H1 2026 showed both the operating leverage (volume +11.5%) and the fragility (gross margin −5pp on tariffs and input costs) of that model. The second company is a holding vehicle: about US$176m of cash and portfolio assets, modest bank debt, and a 30% stake in KKR-controlled NVC China carried at US$116m that is slipping into losses.

The equity market values the whole at roughly US$42m, about 0.09x book and a negative enterprise value. That discount is not irrational. Shareholders have received no dividends since 2020, cash was redeployed into a US$50m discretionary investment mandate rather than distributed, the CEO post has been vacant for 17 months with the chairman covering, and control is concentrated in a family vehicle. Reported earnings are dominated by associate impairments, reversals and FX, which makes the stock almost uninvestable for fundamental institutions and leaves it illiquid (≈60k shares a day).

Our assessment: the margin of safety on assets is exceptional, but realisation depends entirely on controlling-shareholder decisions over which minorities have no leverage. Absent a capital-return policy, a credible CEO appointment, or a transaction around the NVC China stake, the discount is likely to persist and could widen if the BLIHP stake is impaired again. Stance: deep value / value trap, with event-dependent upside. Monitor capital allocation and the FY2026 BLIHP impairment test.